Stereotactic Administration of Intratumoral Chronic Chemotherapy of Recurrent Malignant Gliomas
- 1 January 1987
- journal article
- Published by S. Karger AG in Stereotactic and Functional Neurosurgery
- Vol. 50 (1-6) , 223-226
- https://doi.org/10.1159/000100713
Abstract
There is a continuous search for more efficient treatment of malignant cerebral gliomas. The work of Penn and Croin [9] demonstrates clearly that survival of rats having experimental gliomas is significantly increased by intratumoral chemotherapy. It has been shown that chronic depth electrodes for the investigation of epileptic patients is a reliable and safe method. Using this proven technology originally developed by Talairach, Szikla and co-workers we have developed catheters for intratumoral chemotherapy. Three patients have been treated. It is premature to pretend that this is a treatment which will lengthen the patient''s life. Nevertheless, the feasibility of the technique, its precision and safety are assured. Following this course of treatment, we have seen no deteriorations, no side effects, no bone marrow depressions, and no sign of toxicity. Chemical analysis has shown that cisplatin was delivered to the tumor.Keywords
This publication has 0 references indexed in Scilit: